Regitine® phentolamine, 10 mg/ml
- Product
Regitine 10 mg/ml, solution for injection
- Authorisation
NL-RVG 01635
- Active ingredient
10 mg/ml phentolamine mesylate
- Indication
Treatment of paroxysmal hypertension before and during pheochromocytoma excision
- Storage condition
At 2 – 8 °C
Regitine can be used for:
- treatment of paroxysmal hypertension before and during pheochromocytoma excision;
- diagnosis of pheochromocytoma (if other, more specific, tests cannot be performed or have given insufficient information);
- prevention of dermal necrosis and sloughing after extravasation of noradrenaline.
Legal status
Regitine is a licensed medicine in the Netherlands.
When this medicine is supplied outside the Netherlands, it is considered to be an unlicensed medicine in the country of the recipient.
Availability for (Hospital) Pharmacies
In the Netherlands, Regitine is distributed to hospital pharmacies by the pharmaceutical wholesalers.
Hospital Pharmacies outside the Netherlands that would like to know more about the availability of this product are welcome to contact us via our contact form.
